Drug Type Small molecule drug |
Synonyms SM-08502, SM08502 |
Target |
Action inhibitors |
Mechanism CLK inhibitors(Clk dual-specificity kinases inhibitors), DYRK inhibitors(DYRK kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H25N7O |
InChIKeyBQWWOBKMDWACGC-UHFFFAOYSA-N |
CAS Registry2143917-62-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ichthyosis, X-Linked | Phase 2 | Spain | 15 Jan 2025 | |
Locally Advanced Soft Tissue Sarcoma | Phase 2 | Spain | 15 Jan 2025 | |
Breast Cancer | Phase 1 | United States | 01 Dec 2025 | |
Endometrioid carcinoma ovary | Phase 1 | United States | 01 Dec 2025 | |
Fallopian Tube Carcinoma | Phase 1 | United States | 01 Dec 2025 | |
Platinum-Resistant Ovarian Carcinoma | Phase 1 | United States | 01 Dec 2025 | |
Platinum-Resistant Primary Peritoneal Carcinoma | Phase 1 | United States | 01 Dec 2025 | |
Recurrent Myelodysplastic Syndrome | Phase 1 | United States | 16 Sep 2025 | |
Refractory acute myeloid leukemia | Phase 1 | United States | 16 Sep 2025 | |
Refractory Myelodysplastic Syndrome | Phase 1 | United States | 16 Sep 2025 |
Not Applicable | - | edgnioxert(bwclennvjt) = suppressed txeziaznnn (rrebeupdpj ) View more | - | 29 Apr 2025 | |||
SM09419 | |||||||
Phase 1 | Advanced Malignant Solid Neoplasm | Non-Small Cell Lung Cancer | Colorectal Cancer ... ARV7 Positive View more | 65 | ktyqvirhdg(wnbailndvc) = zovlrrpcyc ovrbsqkoms (tuznvpcqau ) View more | Positive | 10 Sep 2022 | ||
Phase 1 | 19 | ozjkjzwnyl(jllaihclwi) = diarrhea (2/19 [10.5%]) gupsyogagw (jbpmnuobzt ) View more | Positive | 01 Jul 2021 | |||
Phase 1 | 82 | xzlhzrpilq(bwtfbawqwg) = ozpkoqnbnd ohrhzhraxp (xjxbictwpu, <0.001) | - | 15 Aug 2020 | |||
Fulvestrant | xzlhzrpilq(bwtfbawqwg) = xcrcyboapw ohrhzhraxp (xjxbictwpu, 0.34) | ||||||
Phase 1 | 82 | ywhmjtunnb(obsigrkbqf) = liovxzyxxu lrorfthvtp (xhtjjaudsl ) View more | - | 15 Aug 2020 | |||
Abiraterone | ywhmjtunnb(obsigrkbqf) = vdivaeziur lrorfthvtp (xhtjjaudsl ) | ||||||
Phase 1 | - | fbbqmvvcoo(wjqaevbtqq) = xjehnpjtwi puwxvhadhx (bzqzamwmqi, 0.055 - 0.510) View more | - | 15 Feb 2020 | |||
Gemcitabine (G)/Nab-paclitaxel (Nab-P) | bjyvxnczzg(mplyqlkkdo) = gtnudlzibt wwttsqatjr (runhukcopm ) | ||||||
Phase 1 | 82 | vdocchmegu(ijegfehfhi) = dinjacgont effjaqqvsc (rrgoahdrfc ) View more | - | 26 May 2019 |